|
Re: This late June meeting, warrants about to expire???
|
5
|
Resverlogix Corp.
|
Apr 09, 2021 02:28PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
5
|
Zenith Epigenetics
|
Aug 12, 2017 05:53PM
|
|
Re: Tada's wing a prayer list ...
|
5
|
Resverlogix Corp.
|
Sep 27, 2019 01:27PM
|
|
Re: Question re Hepa
|
5
|
Resverlogix Corp.
|
Oct 18, 2017 11:53AM
|
|
Re: A Cluster muck....
|
5
|
Resverlogix Corp.
|
Jun 06, 2019 05:54PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
5
|
Resverlogix Corp.
|
Mar 11, 2019 09:38AM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
5
|
Resverlogix Corp.
|
Apr 12, 2018 05:42PM
|
|
Re: Analyst Coverage, etc.
|
5
|
Resverlogix Corp.
|
May 07, 2017 07:57PM
|
|
Re: How much of a drag is the "going concern" flag on the stock's valuation?
|
5
|
Resverlogix Corp.
|
Mar 30, 2019 03:37PM
|
|
Re: Renal and Fabry trial listings updated on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Apr 21, 2018 04:32PM
|
|
Re: Buyout?......
|
5
|
Resverlogix Corp.
|
Jun 02, 2019 08:50PM
|
|
Re: Avoid The Bag - Blog post preview....
|
5
|
Resverlogix Corp.
|
Mar 30, 2017 03:14PM
|
|
Re: 3 ASN Kidney Conference Presentations Nov 8-9
|
5
|
Resverlogix Corp.
|
Nov 08, 2019 04:39PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 04:00PM
|
|
Next News Release
|
5
|
Resverlogix Corp.
|
May 15, 2017 03:02PM
|
|
Re: Debenture
|
5
|
Resverlogix Corp.
|
Sep 27, 2019 01:53PM
|
|
Re: Food For Thought
|
5
|
Resverlogix Corp.
|
Oct 19, 2019 03:51PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
5
|
Resverlogix Corp.
|
Nov 02, 2020 07:32PM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Aug 07, 2020 02:43PM
|
|
Your thoughts please
|
4
|
Resverlogix Corp.
|
Sep 04, 2024 12:17AM
|
